Fig. 2
From: Safety and efficacy of biological agents in the treatment of Systemic Lupus Erythematosus (SLE)
Serious adverse events
Fig. 2 | BMC Rheumatology
From: Safety and efficacy of biological agents in the treatment of Systemic Lupus Erythematosus (SLE)
Serious adverse events